title: FDG PET/CT in the management of nasopharyngeal carcinoma.
abstract: OBJECTIVE
  FDG PET/CT has a growing role in the diagnosis and management of nasopharyngeal carcinoma (NPC). FDG PET has greater efficacy for N and M staging than other modalities, which enables the treating oncologists to select the appropriate mode of treatment. FDG PET/CT helps in radiation therapy planning, provides valuable prognostic information, and is useful in the assessment of therapy response and in follow-up to detect recurrences.
  
  
  CONCLUSIONS
  FDG PET/CT is a valuable imaging test in the management of NPC.
authors: 1 Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins School of Medicine, 601 N Caroline St, JHOC 3235, Baltimore, MD 21287.
authors: Aravind
authors: A
authors: Mohandas
authors: Charles
authors: C
authors: Marcus
authors: Hyunseok
authors: H
authors: Kang
authors: Minh-Tam
authors: MT
authors: Truong
authors: Rathan M
authors: RM
authors: Subramaniam
mesh_terms: D002277:Carcinoma; D019788:Fluorodeoxyglucose F18; D006801:Humans; D064847:Multimodal Imaging; D000077274:Nasopharyngeal Carcinoma; D009303:Nasopharyngeal Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography / Q000379:methods*; D011379:Prognosis; D019275:Radiopharmaceuticals; D011880:Radiotherapy Planning, Computer-Assisted; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: PET/CT; nasopharyngeal cancer; patient outcome; radiation therapy planning